349 related articles for article (PubMed ID: 19291294)
41. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
42. The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.
Hoffmann FS; Kuhn PH; Laurent SA; Hauck SM; Berer K; Wendlinger SA; Krumbholz M; Khademi M; Olsson T; Dreyling M; Pfister HW; Alexander T; Hiepe F; Kümpfel T; Crawford HC; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
J Immunol; 2015 Jan; 194(2):542-52. PubMed ID: 25505277
[TBL] [Abstract][Full Text] [Related]
43. Methylation of TNFRSF13B and TNFRSF13C in duodenal mucosa in canine inflammatory bowel disease and its association with decreased mucosal IgA expression.
Maeda S; Ohno K; Fujiwara-Igarashi A; Tomiyasu H; Fujino Y; Tsujimoto H
Vet Immunol Immunopathol; 2014 Jul; 160(1-2):97-106. PubMed ID: 24814046
[TBL] [Abstract][Full Text] [Related]
44. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature.
Moreaux J; Cremer FW; Reme T; Raab M; Mahtouk K; Kaukel P; Pantesco V; De Vos J; Jourdan E; Jauch A; Legouffe E; Moos M; Fiol G; Goldschmidt H; Rossi JF; Hose D; Klein B
Blood; 2005 Aug; 106(3):1021-30. PubMed ID: 15827134
[TBL] [Abstract][Full Text] [Related]
45. Expression of TNF-α, APRIL and BCMA in Behcet's disease.
Shaker OG; Tawfic SO; El-Tawdy AM; El-Komy MH; El Menyawi M; Heikal AA
J Immunol Res; 2014; 2014():380405. PubMed ID: 25759827
[TBL] [Abstract][Full Text] [Related]
46. TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines.
Moreaux J; Hose D; Jourdan M; Reme T; Hundemer M; Moos M; Robert N; Moine P; De Vos J; Goldschmidt H; Klein B
Haematologica; 2007 Jun; 92(6):803-11. PubMed ID: 17550853
[TBL] [Abstract][Full Text] [Related]
47. TACI Isoforms Regulate Ligand Binding and Receptor Function.
Garcia-Carmona Y; Ting AT; Radigan L; Athuluri Divakar SK; Chavez J; Meffre E; Cerutti A; Cunningham-Rundles C
Front Immunol; 2018; 9():2125. PubMed ID: 30333819
[TBL] [Abstract][Full Text] [Related]
48. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
49. The role of BAFF and APRIL in rheumatoid arthritis.
Shabgah AG; Shariati-Sarabi Z; Tavakkol-Afshari J; Mohammadi M
J Cell Physiol; 2019 Aug; 234(10):17050-17063. PubMed ID: 30941763
[TBL] [Abstract][Full Text] [Related]
50. Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta.
Langat DL; Wheaton DA; Platt JS; Sifers T; Hunt JS
Am J Pathol; 2008 May; 172(5):1303-11. PubMed ID: 18403603
[TBL] [Abstract][Full Text] [Related]
51. Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas.
Guadagnoli M; Kimberley FC; Phan U; Cameron K; Vink PM; Rodermond H; Eldering E; Kater AP; van Eenennaam H; Medema JP
Blood; 2011 Jun; 117(25):6856-65. PubMed ID: 21543761
[TBL] [Abstract][Full Text] [Related]
52. Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection.
Afzali S; Salehi S; Shahi A; Esmaeili M; Farashi Bonab S; Peykari A; Bagherpour F; Ansaripour B; Soleimanian T; Pour-Reza-Gholi F; Amirzargar A
J Immunol Res; 2021; 2021():6654992. PubMed ID: 33748289
[TBL] [Abstract][Full Text] [Related]
53. The Correlation Between Non-Hodgkin Lymphoma and Expression Levels of B-Cell Activating Factor and Its Receptors.
Shen X; Wang M; Guo Y; Ju S
Adv Clin Exp Med; 2016; 25(5):837-844. PubMed ID: 28028945
[TBL] [Abstract][Full Text] [Related]
54. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.
Novak AJ; Darce JR; Arendt BK; Harder B; Henderson K; Kindsvogel W; Gross JA; Greipp PR; Jelinek DF
Blood; 2004 Jan; 103(2):689-94. PubMed ID: 14512299
[TBL] [Abstract][Full Text] [Related]
55. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.
Jacob CO; Yu N; Guo S; Jacob N; Quinn WJ; Sindhava V; Cancro MP; Goilav B; Putterman C; Migone TS; Stohl W
Arthritis Rheum; 2013 Apr; 65(4):1043-54. PubMed ID: 23334904
[TBL] [Abstract][Full Text] [Related]
56. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.
Min YN; Wang CY; Li XX; Hou Y; Qiu JH; Ma J; Shao LL; Zhang X; Wang YW; Peng J; Hou M; Shi Y
J Thromb Haemost; 2016 Mar; 14(3):559-71. PubMed ID: 26749059
[TBL] [Abstract][Full Text] [Related]
57. Shedding of BAFF/APRIL Receptors Controls B Cells.
Meinl E; Thaler FS; Lichtenthaler SF
Trends Immunol; 2018 Sep; 39(9):673-676. PubMed ID: 30072119
[TBL] [Abstract][Full Text] [Related]
58. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.
Vincent FB; Saulep-Easton D; Figgett WA; Fairfax KA; Mackay F
Cytokine Growth Factor Rev; 2013 Jun; 24(3):203-15. PubMed ID: 23684423
[TBL] [Abstract][Full Text] [Related]
59. APRIL promotes proliferation, secretion and invasion of fibroblast-like synoviocyte from rats with adjuvant induced arthritis.
Chang Y; Jia X; Sun X; Xu S; Wu Y; Zhang L; Wei W
Mol Immunol; 2015 Mar; 64(1):90-8. PubMed ID: 25466610
[TBL] [Abstract][Full Text] [Related]
60. CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism.
Nelke J; Medler J; Weisenberger D; Beilhack A; Wajant H
MAbs; 2020; 12(1):1807721. PubMed ID: 32840410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
